(269 days)
The OLSEN Medical Electrosurgical Monopolar and Bipolar Forceps are intended to be used as active electrosurgical devices where monopolar or bipolar electrosurgical cutting and coagulation is desired during surgery and are intended to grasp, manipulate cut or coagulate selected soft tissue.
OLSEN Medical® Electrosurgical Monopolar and Bipolar Forceps have been designed as active electrosurgical instruments to grasp, manipulate, cut or coagulate selected soft tissue. These stainless steel forceps are connected through a suitable active electrosurgical cable (bipolar or monopolar) to the specified output terminal of an electrosurgical generator. The bipolar forceps are intended for use with a maximum voltage of 500 volts while the monopolar forceps have a maximum voltage of 2000 volts. The forceps are offered either as single (disposable) or multiple-use (reuseable).
This document is a 510(k) Premarket Notification for Olsen Medical Bipolar and Monopolar Forceps. It primarily focuses on demonstrating substantial equivalence to predicate devices for regulatory clearance, rather than presenting a study to prove acceptance criteria for a novel artificial intelligence or software-as-a-medical-device (SaMD) product.
Therefore, many of the requested categories for AI/SaMD performance studies (like sample size for test set, number of experts, adjudication methods, MRMC studies, standalone performance, training set details) are not applicable to the information provided in this 510(k) submission.
However, I can extract the relevant information regarding acceptance criteria and the type of studies performed to show device safety and equivalence.
Here's the information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Specific Standard/Requirement | Reported Device Performance / Outcome |
|---|---|---|
| Electrical Safety | IEC 60601-2-2 (High Frequency Surgical Equipment) | Successful outcome |
| Sterilization | ANSI/AAMI/ISO 11137-2 (Radiation Sterilization Dose) | Successful outcome |
| Biocompatibility | ISO 10993 Part 5 (In vitro cytotoxicity) | Successful outcome |
| Electrosurgical Device Standards | ANSI/AAMI HF18-1993 (Electrosurgical Devices) | Successful outcome |
| Intended Use Equivalence | To be used as active electrosurgical devices where monopolar or bipolar electrosurgical cutting and coagulation is desired during surgery and are intended to grasp, manipulate cut or coagulate selected soft tissue. | "The subject devices also have the same intended use and performance characteristics as their predicates. No new technological characteristics were introduced..." |
| Design Equivalence | Similar in design to predicates | "The proposed Olsen Bipolar and Monopolar Forceps is similar in design as its predicates." |
| Materials/Processes Equivalence | Sterilized using equivalent materials and processes as predicates. | "The Olsen Forceps are sterilized using equivalent materials and processes as its predicates." |
| Safety and Effectiveness | No new types of safety and effectiveness issues compared to predicates. | "...the proposed forceps do not raise new types of safety and effectiveness issues as compared to the predicates." |
2. Sample Size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- Not applicable. This document describes a 510(k) submission for conventional medical devices (bipolar and monopolar forceps), not an AI/SaMD. The "testing" refers to compliance with established international and national standards for medical device safety and performance (e.g., electrical safety, sterilization, biocompatibility), rather than a clinical study with a "test set" of patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- Not applicable. See point 2. Ground truth in the context of AI/SaMD studies involves expert interpretations of data. For these forceps, "ground truth" is adherence to engineering and safety standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Not applicable. See point 2.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- No. This type of study is specifically for evaluating AI/SaMD performance in a clinical setting involving human readers/interpreters. It's not relevant for assessing electrosurgical forceps.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- No. This is not software or an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- The "ground truth" for these devices is adherence to established engineering, electrical, biological, and sterilization standards for electrosurgical equipment (e.g., IEC 60601-2-2, ISO 10993, ANSI/AAMI HF18, ANSI/AAMI/ISO 11137-2). The ultimate validation is "substantial equivalence" to legally marketed predicate devices, meaning they function and are as safe and effective as existing, cleared devices.
8. The sample size for the training set
- Not applicable. No AI model is being trained.
9. How the ground truth for the training set was established
- Not applicable. No AI model is being trained.
{0}------------------------------------------------
Page 1 of 3
510(k) Premarket Notification Olsen Medical Bipolar and Monopolar Forceps
510(k) Summary Pursuant to 21 CFR 807.92
General Company Information
| Company Name: | Olsen Medical® |
|---|---|
| Company Address: | 3230 Commerce Center PlaceLouisville, Kentucky 40211 |
| Company Telephone: | (502) 772-4280 |
| Contact: | Dalene T. Binkley |
| Contact Address: | 1927 N. Arthur DriveColumbia City, Indiana 46725(260) 244-4189 |
| Date: | October 7, 2013DEC 0 6 2013 |
| Device Trade Name: | Olsen Medical Bipolar and Monopolar Forceps(Single and Multiple-Use) |
| Common Name: | Single Use Bipolar and Monopolar Forceps;Multiple-Use Bipolar and Monopolar Forceps |
| Classification Nameand Reference: | GEI – 878.4400, Electrosurgical cutting andcoagulation device and accessories |
| Predicate Device: | Bipolar Forceps: |
| Dermacare (now Olsen Medical) DisposableBipolar Cord and Bipolar Forcep, K884656,cleared November 25, 1988 | |
| Olsen Medical Midas Touch Bipolar Forceps,K982705, cleared September 8, 1998 | |
| Stryker Bipolar Forceps, K093108, cleared June22, 2010 |
{1}------------------------------------------------
510(k) Premarket Notification Olsen Medical Bipolar and Monopolar Forceps
Page 2 of 3
Monopolar Forceps:
Boston Surgical Products Reusable Monopolar Forceps, K950877, cleared March 9, 1995
Device Description:
OLSEN Medical® Electrosurgical Monopolar and Bipolar Forceps have been designed as active electrosurgical instruments to grasp, manipulate, cut or coagulate selected soft tissue. These stainless steel forceps are connected through a suitable active electrosurgical cable (bipolar or monopolar) to the specified output terminal of an electrosurgical generator. The bipolar forceps are intended for use with a maximum voltage of 500 volts while the monopolar forceps have a maximum voltage of 2000 volts. The forceps are offered either as single (disposable) or multiple-use (reuseable).
Intended Use:
The OLSEN Medical Electrosurgical Monopolar and Bipolar Forceps are intended to be used as active electrosurgical devices where monopolar or bipolar electrosurgical cutting and coagulation is desired during surgery and are intended to grasp, manipulate cut or coagulate selected soft tissue.
Comparison to Predicate Device:
The proposed Olsen Bipolar and Monopolar Forceps is similar in design as its predicates. The Olsen Forceps are sterilized using equivalent materials and processes as its predicates. The subject devices also have the same intended use and performance characteristics as their predicates. No new technological characteristics were introduced and as such, the proposed forceps do not raise new types of safety and effectiveness issues as compared to the predicates.
Testing and Technological Characteristics:
The Olsen Medical Bipolar and Monopolar Forceps are active electrosurgical devices that provide an electrical current that is fired through the tips of the forceps. The devices are hand-held and provided sterile for the single use forceps and non-sterile for the multiple use forceps. The forceps connect to a corresponding power cord (bipolar or monopolar).
{2}------------------------------------------------
510(k) Premarket Notification Olsen Medical Bipolar and Monopolar Forceps
The following testing was conducted with successful outcome to establish device safety and equivalence:
- IEC 60601-2-2 Medical Electrical Equipment/Part 2-2: Particular . Requirements for Safety of High Frequency Surgical Equipment
- . ANSI/AAMI/ISO 11137-2:2006: Sterilization of Health Care Products -Radiation - Part 2: Establishing the sterilization dose
- ISO 10993: Biological evaluation of medical devices Part 5: Tests for in . vitro cytotoxicity
- ANSI/AAMI HF18-1993 American National Standard for Electrosurgical . Devices
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
Olsen Medical % Ms. Dalene T. Binkley FDC Services, LLC 1927 N. Arthur Drive Columbia City, Indiana 46725
December 6, 2013
Re: K130669
Trade/Device Name: Olsen Medical® Bipolar and Monopolar Forceps Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: October 7, 2013 Received: October 11, 2013
Dear Ms. Binkley:
We have reviewed your Section 510(k) premarket notification of intent to market the device w & nove and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 10 use sured in the enorse. 976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). and Cosinction room in the device, subject to the general controls provisions of the Act. The r ou may, merelory, manss of the Act include requirements for annual registration, listing of general ookies provision practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be It may be subject to additions, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean r lease of advised that I Dr 3 lesaants or our device complies with other requirements of the Act that I DA has Indo a dolorimians administered by other Federal agencies. You must or any I collares and regulances and regulations but not limited to: registration and listing (21 Comply will an the Fee 316quirements (1); medical device reporting (reporting of medical CrK Fall 807), labeling (21 OFR 803); good manufacturing practice requirements as set
{4}------------------------------------------------
Page 2 - Ms. Dalene T. Binkley
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Joshua C. Nipper -S
Binita S. Ashar, M.D., M.B.A., F.A.C.S. Acting Director For Division of Surgical Devices Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
ктзоева
510(k) Number (if Known):
Device Name: Device Name: Olsen Medical® Bipolar and Monopolar Forceps
Indications For Use: The OLSEN Medical Electrosurgical Monopolar and Bipolar Forceps are intended to be used as active electrosurgical devices where monopolar or bipolar electrosurgical cutting and coagulation is desired during surgery and are intended to grasp, manipulate cut or coagulate selected soft tissue.
Prescription Use: _ X
OR Over-The-Counter Use: (Part 21 CFR 807.109)
PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
Deptably vigned by Lang H. Chen A.
DH: cell), oversel, overnment, and C.C.
ous FDA, corecolor coments of C.C. C.
ourse F.DA, council coll. L. L. L. L. L. L. L. L. L. L. L. L. Long H. Chen - A . for BSA
노하우드 트래프 # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # #
(Division Sign-off) Division of Surgical Devices 510(k) Number: K130669 17
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.